Qtron Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Qtron Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$480K	Buy	+1,992	New	+$436K	0.06%	333
2024 Q3	–	Sell	-5,462	Closed	-$583K	–	455
2024 Q2	$583K	Hold	5,462	–	–	0.08%	284
2024 Q1	$658K	Buy	5,462 +2,525	+86%	+$309K	0.09%	284
2023 Q4	$361K	Hold	2,937	–	–	0.06%	387
2023 Q3	$380K	Sell	2,937 -1,063	-27%	-$142K	0.07%	333
2023 Q2	$496K	Hold	4,000	–	–	0.09%	280
2023 Q1	$585K	Hold	4,000	–	–	0.12%	232
2022 Q4	$637K	Buy	4,000 +1,764	+79%	+$259K	0.13%	210
2022 Q3	$298K	Buy	+2,236	New	+$340K	0.07%	332
2021 Q3	–	Sell	-3,652	Closed	-$649K	–	336
2021 Q2	$649K	Hold	3,652	–	–	0.16%	185
2021 Q1	$600K	Hold	3,652	–	–	0.17%	169
2020 Q4	$603K	Buy	3,652 +550	+18%	+$81.9K	0.16%	160
2020 Q3	$442K	Buy	3,102 +920	+42%	+$114K	0.15%	160
2020 Q2	$241K	Buy	+2,182	New	+$241K	0.1%	230

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Qtron Investments's JAZZ Position: Q2 2026 in Review

Qtron Investments opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 1,992 shares worth $480K. The stake represents 0.06% of the portfolio and ranks #333 among its holdings. This is a return to the name: Qtron Investments previously reported a position in JAZZ as recently as Q2 2024.

Qtron Investments first reported a position in JAZZ in Q2 2020 and has held it in 14 quarters since. The position peaked at $658K in Q1 2024. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Qtron Investments held 1,992 shares of Jazz Pharmaceuticals worth $480K as of Q2 2026.
Jazz Pharmaceuticals was a new Qtron Investments position in Q2 2026.
Jazz Pharmaceuticals made up 0.06% of Qtron Investments's portfolio in Q2 2026, its #333 holding.
Qtron Investments first reported a position in Jazz Pharmaceuticals in Q2 2020 and has held it in 14 quarters since.
Qtron Investments's Jazz Pharmaceuticals position peaked at $658K in Q1 2024.
646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Qtron Investments's 13F filing for Q2 2026, filed 13 Aug 2026.